Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Luis Jodar, PhD
Chief Scientific Officer
Pfizer Vaccines
Disclosure(s): Pfizer Inc: Stocks/Bonds (Public Company)
Poster(s):
(P-605) Burden of Hospitalizations Due to Respiratory Syncytial Virus in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-1428) Real-World Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine among Adults 65-74, 75-84, and ≥85 Years of Age in the United States
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1484) How do recent population-level RSVpreF vaccine impact results from the United Kingdom relate to previously reported vaccine effectiveness results?
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
